MedPath

A randomised control trial investigating the effect of remote ischaemic preconditioning and glyceryl trinitrate on peri-operative myocardial injury in cardiac bypass surgery patients (ERIC-GTN study)

Phase 1
Conditions
We are investigating the phenomenon of ischaemic-reperfusion injury. Reperfusion of the ischaemic myocardium is known to cause further myocardial damage. We wish to investigate the phenomenon of Remote Ischaemic Preconditionoing along with Glyceryl Trinitrate to reduce reperfusion injury.
MedDRA version: 16.0Level: PTClassification code 10051624Term: Myocardial reperfusion injurySystem Organ Class: 10007541 - Cardiac disorders
Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Registration Number
EUCTR2013-001922-24-GB
Lead Sponsor
niversity College London (UCL)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
260
Inclusion Criteria

1.Adult patients (>18 years old) undergoing CABG and/or valve surgery involving cardiopulmonary bypass capable of consenting themselves.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 36
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 200

Exclusion Criteria

1.Allergies to excipients of IMP and placebo
2.Chronic Renal failure (eGFR<30 ml/min/kg)
3.Severe liver disease
4.Peripheral arterial disease
5.Pregnant or lactating women
6.Any other contraindications to glyceryl trinitrate as per the summary of product characteristics.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath